ALGORITHM OF MANAGEMENT OF PATIENTS WITH SYMPTOMS OF VULVOVAGINAL ATROPHY/GENITOURINARY MENOPAUSAL SYNDROME

1. Portman D.J., Gass M.L. Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and the North American Menopause Society. Menopause. 2014; 21(10): 1063-8. https://doi.org/10.1097/GME.0000000000000329.

2. Юренева С.В., Ермакова Е.И., Глазунова А.В. Диагностика и терапия генитоуринарного менопаузального синдрома у пациенток в пери- и постменопаузе (краткие клинические рекомендации). Акушерство и гинекология. 2016; 5: 138-44. [Yureneva S.V., Ermakova E.I., Glazunova A.V. Genitourinary syndrome of menopause in peri- and postmenopausal patients: Diagnosis and therapy (short clinical guideline). Obstetrics and Gynecology. 2016; 5: 138-44. (in Russian)]. https://dx.doi.org/10.18565/aig.2016.5.138-144.

3. The North American Menopause Society. Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. 2013; 20(9): 888-902; quiz 903-4. https://doi.org/10.1097/GME.0b013e3182a122c2.

4. Frank S.M., Ziegler C., Kokot-Kierepa M., Maamari R., NappiR.E. Vaginal Health: Insights, Views & Attitudes (VIVA) survey — Canadian cohort. Menopause. 2013; 19(1): 20-7. https://doi.org/10.1258/mi.2012.012034.

5. Briggs P. Genitourinary syndrome of menopause. Post Reprod. Healh. 2020; 26(2): 111-4. https://doi.org/10.1177/2053369119884144.

6. Министерство здравоохранения Российской Федерации. Клинические рекомендации «Менопауза и климактерическое состояние у женщин». 2021. https://cr.minzdrav.gov.ru/recomend/117_2 [Ministry of Health of the Russian Federation. Clinical recommendations „Menopause and menopausal condition in women”. 2021. (in Russian)]. https://cr.minzdrav.gov.ru/recomend/117_2

7. Rueda C., Osorio A.M., Avellaneda A.C., Pinzon C.E., Restrepo O.I. The efficacy and safety of estriol to treat vulvovaginal atrophy in postmenopausal women: a systematic literature review. Climacteric. 2017; 20(4): 321-30. https://doi.org/10.1080/13697137.2017.1329291.

8. Weidlinger S., Schmutz C., Janka H., Gruetter C., Stute P. Sustainability of vaginal estrogens for genitourinary syndrome of menopause — a systematic review. Climacteric. 2021; 24(6): 551-9. https://doi.org/10.1080/13697137.2021.1891218.

9. Hirschberg A.L., Bitzer J., Cano A., Ceausu I., Chedraui P. et al. Topical estrogens and non-hormonal preparations for postmenopausal vulvovaginal atrophy: An EMAS clinical guide. Maturitas. 2021; 148: 55-61. https://doi.org/10.1016/j.maturitas.2021.04.005.

10. Tersigni C., Di Simone N., Tempestilli E., Cianfrini F., Russo R., Moruzzi M.C. et al. Non-hormonal treatment of vulvo-vaginal atrophy-related symptoms in post-menopausal women. J Obstet Gynaecol. 2015; 35(8): 835-8. https://doi.org/10.3109/01443615.2015.1014326.

11. Hirschberg A.L., Bitzer J., Cano A., Ceausu L., Chedraui P. et al. Topical estrogens and non-hormonal preparations for postmenopausal vulvovaginal atrophy: An EMAS clinical guide. Maturitas. 2021; 148: 55-61. https://doi.org/10.1016/j.maturitas.2021.04.005.

12. dos Santos C.C.M., Uggioni M.L.R., Colonetti T., Colonetti L., Grande A.J., Da Rosa M.I. Hyaluronic Acid in Postmenopause Vaginal Atrophy: A Systematic Review. J Sex Med. 2021;18(1): 156-66. https://doi.org/10.1016/j.jsxm.2020.10.016.

13. Lima S.M.R.R., Honorato J.V., Silva M.A.L.G. Glycine Max (L.) Merr isoflavone gel improves vaginal vascularization in postmenopausal women. Climacteric. 2020; 23(5): 505-10. https://doi.org/10.1080/13697137.2020.1752172.

14. Доброхотова Ю.Э., Ильина И.Ю., Венедиктова М.Г., Морозова К.В., Суворова В.А. Локальная негормональная терапия больных с генитоуринарным менопаузальным синдромом. Российский вестник акушера-гинеколога. 2018; 18(3): 88-94. [Dobrokhotova Iu.E., Ilyina I.Yu., Venediktova M.G., Morozova K.V., Suvorova V.A. Local nonhormonal therapy in patients with genitourinary menopausal syndrome. Russian Bulletin of Obstetrician-Gynecologist. 2018; 18(3): 8894. (in Russian)]. https://doi.org/10.17116/rosakush201818288-94.

15. Инструкция-аннотация по применению крема по интимной гигиене дозированного «Эстрогиал плюс», «Эстрогиал», инструкция-аннотация по применению интимного геля «Эстрогиал Гель». СГР: №BY.70.06.01.001.E.003744.09.16,CrP: № KG 11.01.09.001.R.004986.11.19 от 21.11.2019, СГР: № KG 11.01.09.001.R.004985.11.19 от 21.11.2019. [Instruction-annotation on the use of cream for intimate hygiene dosed „Estrogial plus”, „Estrogial”, instructionannotation on the use of intimate gel „Estrogial Gel”. SGR: NO.BY.70.06.01.001.E.003744.09.16,SGR: No. KG 11.01.09.001.R.004986.11.19 of 21.11.2019, SGR: No. KG 11.01.09.001.R.004985.11.19 of 21.11.2019. (in Russian)].